Filing Flows › Orchestra BioMed Holdings (OBIO) › How it makes money
How Orchestra BioMed Holdings (OBIO) makes money
Orchestra BioMed Holdings (OBIO) made $88K of revenue in the second quarter 2026 (Q2 2026), -89% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $88K | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $88K | -90% |
| Q1 2026 | $110K | -87% |
| Q4 2025 | $30.9M | 122× |
| Q3 2025 | $861K | -13% |
| Q2 2025 | $836K | +8% |
| Q1 2025 | $868K | +40% |
| Q4 2024 | $253K | -3% |
From Orchestra BioMed Holdings' 10-Q filed Aug 10, 2026 (on EDGAR).
Questions
How does Orchestra BioMed Holdings make money?
Orchestra BioMed Holdings (OBIO) made $88K of revenue in the second quarter 2026 (Q2 2026), -89% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.